Adjuvant chemotherapy in elderly patients: An analysis of national cancer institute of Canada clinical trials group and intergroup JBR.10

被引：0
|
作者：
Pepe, C.
Hasan, B.
Winton, T.
Seymour, L.
Pater, J.
Livingston, R.
Johnson, D.
Rigas, J.
Ding, K.
Shepherd, F. A.
机构：
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2006年 / 60卷
关键词：
D O I：
10.1016/S1040-8428(13)70021-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S6 / S7
页数：2
相关论文
共 50 条
  • [31] SarCNU in recurrent or metastatic colorectal cancer: A phase II study of the National Cancer Institute of Canada Clinical Trials Group
    Wong, RP
    Baetz, T
    Krahn, MJ
    Biagi, J
    Wainman, N
    Eisenhauer, E
    INVESTIGATIONAL NEW DRUGS, 2006, 24 (04) : 347 - 351
  • [32] SarCNU in recurrent or metastatic colorectal cancer: A phase II study of the National Cancer Institute of Canada Clinical Trials Group
    R. P. Wong
    T. Baetz
    M. J. Krahn
    J. Biagi
    N. Wainman
    E. Eisenhauer
    Investigational New Drugs, 2006, 24 : 347 - 351
  • [33] Defining the optimal treatment strategy for localized prostate cancer patients: a survey of ongoing studies at the National Cancer Institute of Canada Clinical Trials Group
    Parulekar, W. R.
    McKenzie, M.
    Chi, K. N.
    Klotz, L.
    Catton, C.
    Brundage, M.
    Ding, K.
    Hiltz, A.
    Meyer, R.
    Saad, F.
    CURRENT ONCOLOGY, 2008, 15 (04) : 179 - 184
  • [34] Fatigue in patients with cancer: results with National Cancer Institute of Canada Clinical Trials Group studies employing the EORTC QLQ-C30
    J. L. Pater
    Benny Zee
    Michael Palmer
    Dianne Johnston
    David Osoba
    Supportive Care in Cancer, 1997, 5 : 410 - 413
  • [35] The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers - a study of the National Cancer Institute of Canada Clinical Trials Group
    Ma, BBY
    Oza, A
    Eisenhauer, E
    Stanimir, G
    Carey, M
    Chapman, W
    Latta, E
    Sidhu, K
    Powers, J
    Walsh, W
    Fyles, A
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2004, 14 (04) : 650 - 658
  • [36] Fatigue in patients with cancer: Results with National Cancer Institute of Canada clinical trials group studies employing the EORTC QLQ-C30
    Pater, JL
    Zee, B
    Palmer, M
    Johnston, D
    Osoba, D
    SUPPORTIVE CARE IN CANCER, 1997, 5 (05) : 410 - 413
  • [37] Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: Results from IALT, JBR.10 and ANITA
    Graziano, Stephen L.
    Lacas, Benjamin
    Vollmer, Robin
    Kratzke, Robert
    Popper, Helmut
    Filipits, Martin
    Seymour, Lesley
    Shepherd, Frances A.
    Rosell, Rafael
    Veillard, Anne Sophie
    Taron, Miquel
    Pignon, Jean-Pierre
    LUNG CANCER, 2013, 82 (01) : 149 - 155
  • [38] Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group study BR.21
    Bezjak, Andrea
    Tu, Dongsheng
    Seymour, Lesley
    Clark, Gary
    Trajkovic, Aleksandra
    Zukin, Mauro
    Ayoub, Joseph
    Lago, Sergio
    de Albuquerque Ribeiro, Ronaldo
    Gerogianni, Alexandra
    Cyjon, Arnold
    Noble, Jonathan
    Laberge, Francis
    Chan, Raymond Tsz-Tong
    Fenton, David
    von Pawel, Joachim
    Reck, Martin
    Shepherd, Frances A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (24) : 3831 - 3837
  • [39] Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer (NSCLC) treated with adjuvant chemotherapy: results from IALT, JBR.10 and ANITA
    Graziano, Stephen L.
    Azougagh, Said
    Vollmer, Robin
    Kratzke, Robert
    Popper, Helmut
    Filipits, Martin
    Tsao, Ming
    Seymour, Lesley
    Rosell, Rafael
    Taron, Miquel
    Pignon, Jean-Pierre
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S506 - S506
  • [40] MAINTAINING COMPLIANCE IN QUALITY OF LIFE DATA COMPLETION IN CLINICAL TRIALS - THE NATIONAL CANCER INSTITUTE OF CANADA CLINICAL TRIALS GROUP (NCIC CTG) EXPERIENCE
    Bezjak, Andrea
    Palmer, Michael
    Brundage, Michael
    Osoba, David
    Pater, Joseph L.
    QUALITY OF LIFE RESEARCH, 2004, 13 (09) : 1599 - 1599
12345